Although in CLL FCMR is overexpressed and associated with a more aggressive disease [58], in the Eμ-TCL1 transgenic CLL mouse model, FCMR loss confers an aggressive phenotype with transformation to DLBCL [59]. Here, FCMR is linked to B-cell chronic lymphocytic leukemia.